PT Diastika Biotekindo Tbk (ISX:CHEK) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Diastika Biotekindo Tbk Float Percentage Of Total Shares Outstanding?

PT Diastika Biotekindo Tbk ISX:CHEK +1.53% Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 23, 2026. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's float shares is 0.00 Mil. PT Diastika Biotekindo Tbk's total shares outstanding is 4,113.33 Mil. PT Diastika Biotekindo Tbk's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's Institutional Ownership is 0.00%.


PT Diastika Biotekindo Tbk Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PT Diastika Biotekindo Tbk's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/4,113.33
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 23, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PT Diastika Biotekindo Tbk and its competitors.
Is PT Diastika Biotekindo Tbk's Float Percentage Of Total Shares Outstanding too high?
PT Diastika Biotekindo Tbk's current Float Percentage Of Total Shares Outstanding is 0.00%.
How does PT Diastika Biotekindo Tbk's Float Percentage Of Total Shares Outstanding compare to ABT and SYK?
PT Diastika Biotekindo Tbk's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PT Diastika Biotekindo Tbk and its competitors. PT Diastika Biotekindo Tbk's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The current Float Percentage Of Total Shares Outstanding is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.